Dashboard
Manage Tickers

PHAT Phathom Pharmaceuticals, Inc.

Nasdaq phathompharma.com


$ 13.50 $ -0.08 (-0.59 %)    

Friday, 24-Oct-2025 19:57:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 13.53
$ 13.72
$ 12.79 x 1,000
$ 14.53 x 50
$ 13.19 - $ 13.72
$ 2.21 - $ 19.50
505,338
na
959.87M
$ 1.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 03-06-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-07-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-19-2020 12-31-2019 10-K
24 11-25-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

phathom-pharmaceuticals-to-highlight--gastrointestinal-treatments-through-multiple-engagements-including-a-product-theater-presentation-on-voquezna-tablets-for-gerd-at-american-college-of-gastroenterology-2025-annual-scientific-meeting-in-phoenix-arizona
Phathom Pharmaceuticals To Highlight Gast...
10/23/2025 12:14:04

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and commercializing novel treatm...

phathom-pharmaceuticals-appoints-sanjeev-narula-as-chief-financial-and-business-officer
Phathom Pharmaceuticals Appoints Sanjeev N...
10/06/2025 12:11:49

Sanjeev Narula brings proven success in scaling commercial-stage biopharma companies with expertise in capital and investor str...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 21:05:58

phathom-pharmaceuticals-clarifies-that-scheduled-13d-filing-by-frazier-life-sciences-includes-administration-changes-to-reporting-approach-but-does-not-represent-reduction-in-ownership-position-of-any-frazier-fund-or-person-in-phantom
Phathom Pharmaceuticals Clarifies That Sch...
08/20/2025 12:07:02

phathom-pharmaceuticals-sees-fy2025-sales-165000m-175000m-vs-159818m-est
Phathom Pharmaceuticals Sees FY2025 Sales ...
08/07/2025 13:48:12

Phathom Pharmaceuticals (NASDAQ:PHAT) sees FY2025 sales of $165.000 million-$175.000 million vs $159.818 million analyst estimate.

phathom-pharmaceuticals-q2-adj-eps-079-beats-098-estimate-sales-39503m-beat-36383m-estimate
Phathom Pharmaceuticals Q2 Adj. EPS $(0.79...
08/07/2025 11:01:21

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate ...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

phathom-pharmaceuticals-announces-fda-updated-the-orange-book-to-reflect-the-10-year-period-of-non-patent-new-chemical-entity-exclusivity-for-voquezna
Phathom Pharmaceuticals Announces FDA Upda...
06/16/2025 12:08:34

unusual-machines-celldex-therapeutics-rh-and-other-big-stocks-moving-higher-on-friday
Unusual Machines, Celldex Therapeutics, RH...
06/13/2025 14:11:27

craig-hallum-maintains-buy-on-phathom-pharmaceuticals-raises-price-target-to-17
Craig-Hallum Maintains Buy on Phathom Phar...
06/09/2025 14:47:23

Craig-Hallum analyst Chase Knickerbocker maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and raises the price tar...

hc-wainwright--co-reiterates-buy-on-phathom-pharmaceuticals-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Phat...
06/09/2025 11:27:12

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

phathom-pharmaceuticals-stock-doubles-after-fda-grants-full-10-year-exclusivity-for-voquezna
Phathom Pharmaceuticals Stock Doubles Afte...
06/06/2025 19:24:24

Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) shares are trading lower Friday after the company announced a major regulatory win.

needham-maintains-buy-on-phathom-pharmaceuticals-maintains-28-price-target
Needham Maintains Buy on Phathom Pharmaceu...
06/06/2025 18:44:36

Needham analyst Joseph Stringer maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $28 price target.

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
06/06/2025 17:06:47

phathom-pharmaceuticals-shares-resume-trading
Phathom Pharmaceuticals Shares Resume Trading
06/06/2025 16:29:51

phathom-pharmaceuticals-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-1171
Phathom Pharmaceuticals Shares Halted On C...
06/06/2025 16:24:57

phathom-pharmaceuticals-shares-resume-trade
Phathom Pharmaceuticals Shares Resume Trade
06/06/2025 16:23:38

phathom-pharmaceuticals-shares-resume-trade-then-again-halt-on-circuit-breaker-to-the-upside-stock-now-up-1275
Phathom Pharmaceuticals Shares Resume Trad...
06/06/2025 16:16:32

phathom-pharmaceuticals-shares-resume-trade-then-again-halt-on-circuit-breaker-to-the-upside-stock-now-up-802
Phathom Pharmaceuticals Shares Resume Trad...
06/06/2025 15:56:38

phathom-pharmaceuticals-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-591
Phathom Pharmaceuticals Shares Halted On C...
06/06/2025 15:51:27

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION